Overview

Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Bromides
Midodrine
Pyridostigmine Bromide